OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines
Authors:
- Luciana B. FerreiraLFLuciana B. Ferreira
- Raquel T. LimaRaquel T. Lima
- Ana Clara Santos da Fonseca BastosABAna Clara Santos da Fonseca Bastos
- Andreia M. SilvaASAndreia M. Silva
- Catarina TavaresCTCatarina Tavares
- Ana PestanaAPAna Pestana
- Elisabete RiosERElisabete Rios
- Catarina EloyCECatarina Eloy
- Manuel Sobrinho-SimõesMSManuel Sobrinho-Simões
- Etel R. P. GimbaEGEtel R. P. Gimba
- Paula SoaresPaula Soares
Open Access
- 30 September 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (10) , 2990
Abstract
Osteopontin (OPN) spliced variants (OPN-SV: OPNa, OPNb, and OPNc) are aberrantly expressed in tumors and frequently associated with cancer progression. This holds true for papillary thyroid carcinoma (PTC), which is the most common type of thyroid cancer (TC). PTC often presents with desmoplasia and dystrophic calcification, including psammoma bodies (PB). This work aimed to investigate total OPN (tOPN) and OPN-SV expression and their association with the presence of PB in the PTC classical variants (cPTC), as well as the involvement of OPN-SV in matrix calcification of TC cell lines. We found that cPTC samples presenting PB showed higher OPN expression levels. In TC cell lines, OPNa overexpression promotes higher matrix calcification and collagen synthesis when compared to that of clones overexpressing OPNb or OPNc. In response to OPN knockdown, calcification was inhibited, paralleled with the downregulation of calcification markers. In conclusion, our data evidenced that OPN expression is associated with the presence of PB in cPTC samples. Among the OPN-SV, OPNa is the main contributor to matrix calcification in tested TC cells, providing clues to a better understanding on the biology and ethiopathogenesis of the calcification process in TC cells.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (237322/2012-9)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/87887/2012 and SFRH/BD/110617/2015)
- Federación Española de Enfermedades Raras (n/a)
- Operacional Programme for Competitiveness and Internationalization “POCI” (POCI-01-0145-FEDER-007274)
- "Advancing cancer research: from basic knowledgment to application" (NORTE-01-0145-FEDER-000029)
- Projetos Estruturados de I&D&I”, funded by Norte 2020 (n/a)
This publication has 47 references indexed in Scilit:
- The Prognostic Relevance of Psammoma Bodies and Ultrasonographic Intratumoral Calcifications in Papillary Thyroid CarcinomaWorld Journal of Surgery, 2013
- Thyroid cancer cell lines: an overviewFrontiers in Endocrinology, 2012
- Subclassification of non‐solid‐type papillary thyroid carcinoma identification of high‐risk group in common typeCancer Science, 2008
- Papillary thyroid carcinoma: Evidence for intracytoplasmic formation of precursor substance for calcification and its release from well‐preserved neoplastic cellsDiagnostic Cytopathology, 2008
- Microcalcifications and Psammoma Bodies in Thyroid TumorsThyroid®, 2008
- Phosphorylation of Osteopontin Is Required for Inhibition of Calcium Oxalate CrystallizationThe Journal of Physical Chemistry B, 2008
- Thyroid cancer incidence and socioeconomic indicators of health care accessCancer Causes & Control, 2008
- Thyroid calcification and its association with thyroid carcinomaHead & Neck, 2002
- Regulation of Osteopontin Expression in OsteoblastsAnnals of the New York Academy of Sciences, 1995
- Sulphation of secreted phosphoprotein I (SPPI, osteopontin) is associated with mineralized tissue formationBiochemical and Biophysical Research Communications, 1989